Literature DB >> 10395386

In vitro degradation of a novel poly(lactide-co-glycolide) 75/25 foam.

C E Holy1, S M Dang, J E Davies, M S Shoichet.   

Abstract

Macroporous poly(lactide-co-glycolide) PLGA 75/25 foams were prepared for application in bone tissue engineering. Their in vitro degradation behaviour was followed over a 30 week period at 37 degrees C and at one of three pHs: (1) pH 5.0, which mimics the acidic environment produced by activated macrophages, (2) pH 7.4, which reproduces normal physiological conditions and (3) an intermediate pH 6.4. The degradation of the PLGA 75/25 foams was studied by measuring changes in mass, molecular weight and morphology. The degradation profile of foams maintained at pH 5.0, 6.4 and 7.4 was similar until week 16, after which foams maintained at pH 6.4 and 7.4 had comparable degradation patterns whereas foams maintained at pH 5.0 degraded faster. For example, mass loss was less than 3% for foams maintained at all three pHs until week 16; however, by week 30, foams maintained at pH 6.4 and 7.4 had lost 30% of their mass whereas foams maintained at pH 5.0 had lost 90% of their mass. Foams maintained at pH 6.4 and 7.4 showed a similar constant decrease in molecular weight over the entire degradation study. Foams maintained at pH 5.0 had a similar rate of molecular weight loss as those maintained at pH 6.4 and 7.4 until week 16, after which the rate of molecular weight loss of foams maintained at pH 5.0 was accelerated. The morphology of the foams maintained at pH 6.4 and 7.4 was unchanged for 25 weeks. Foams maintained at pH 5.0 collapsed after week 18. Thus the PLGA 75/25 foams, described herein, maintained their 3-D morphology at physiological pH for over 6 months, which is an important feature for tissue engineering applications.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10395386     DOI: 10.1016/s0142-9612(98)00256-7

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  18 in total

1.  Intramuscular delivery of DNA releasing microspheres: microsphere properties and transgene expression.

Authors:  Jae-Hyung Jang; Lonnie D Shea
Journal:  J Control Release       Date:  2006-03-10       Impact factor: 9.776

2.  Immunomodulatory nanoparticles ameliorate disease in the Leishmania (Viannia) panamensis mouse model.

Authors:  Alyssa L Siefert; Allison Ehrlich; María Jesús Corral; Karen Goldsmith-Pestana; Diane McMahon-Pratt; Tarek M Fahmy
Journal:  Biomaterials       Date:  2016-09-06       Impact factor: 12.479

3.  Tunable protein release from acetalated dextran microparticles: a platform for delivery of protein therapeutics to the heart post-MI.

Authors:  Sophia Suarez; Gregory N Grover; Rebecca L Braden; Karen L Christman; Adah Almutairi
Journal:  Biomacromolecules       Date:  2013-10-16       Impact factor: 6.988

Review 4.  Development, characterization and clinical use of a biodegradable composite scaffold for bone engineering in oro-maxillo-facial surgery.

Authors:  John E Davies; Rano Matta; Vanessa C Mendes; Paulo S Perri de Carvalho
Journal:  Organogenesis       Date:  2010 Jul-Sep       Impact factor: 2.500

5.  Sustained release of matrix metalloproteinase-3 to trabecular meshwork cells using biodegradable PLGA microparticles.

Authors:  Sanja Turturro; Suhair Sunoqrot; Hongyu Ying; Seungpyo Hong; Beatrice Y J T Yue
Journal:  Mol Pharm       Date:  2013-07-18       Impact factor: 4.939

6.  Poly(lactide-co-glycolide) porous scaffolds for tissue engineering and regenerative medicine.

Authors:  Zhen Pan; Jiandong Ding
Journal:  Interface Focus       Date:  2012-03-14       Impact factor: 3.906

7.  Next generation miRNA inhibition using short anti-seed PNAs encapsulated in PLGA nanoparticles.

Authors:  Shipra Malik; Jihoon Lim; Frank J Slack; Demetrios T Braddock; Raman Bahal
Journal:  J Control Release       Date:  2020-08-21       Impact factor: 9.776

8.  In vitro and in vivo study of sustained nitric oxide release coating using diazeniumdiolate-oped poly(vinyl chloride) matrix with poly(lactide-co-glycolide) additive.

Authors:  Hitesh Handa; Elizabeth J Brisbois; Terry C Major; Lahdan Refahiyat; Kagya A Amoako; Gail M Annich; Robert H Bartlett; Mark E Meyerhoff
Journal:  J Mater Chem B       Date:  2013-08-07       Impact factor: 6.331

9.  Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier.

Authors:  Hirenkumar K Makadia; Steven J Siegel
Journal:  Polymers (Basel)       Date:  2011-08-26       Impact factor: 4.329

10.  Studies Based on Preparation, Physical Characteristics, and Cellular Pharmacological Activities of Thin PLGA Film Loaded with Geniposide.

Authors:  Haiyan Zhang; Hao Liu; Nan Huang; Ya He; Tingting Lei; Xin Wang; Ming Yang; Guangming Luo
Journal:  Evid Based Complement Alternat Med       Date:  2014-02-12       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.